Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VetrixBio
New Hope, Pennsylvania, United Statesvetrixbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
VetrixBio develops innovative biotherapeutic products for the treatment of cancer and osteoarthritis in companion animals. The company leverages advances from human immunotherapy and regenerative medicine to create disease-modifying therapies that go beyond pain management, aiming for improved outcomes and potential tissue regeneration. No published clinical results or regulatory approvals are available as of May 2025[1][2].
- Therapeutic areas
- OncologyRheumatology
- Modalities
- Biotherapeutics (likely includes biologics and regenerative medicine approaches)[1][2]Immunotherapy[1]Disease-modifying biologic therapies[1]
- Industry
- Veterinary
Beyond the preview
Go deeper on VetrixBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VetrixBio.